Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences

Information for Patients

View all Images (21)

Dengue fever
Other Resources UpToDate PubMed

Dengue fever

Contributors: Casey P. Schukow DO, Vivian Wong MD, PhD, Susan Burgin MD, Paritosh Prasad MD
Other Resources UpToDate PubMed

Synopsis

Dengue fever, also known as breakbone fever, is caused by an RNA-containing flavivirus transmitted to humans by day-biting mosquitoes, notably Aedes aegypti. It is endemic in tropical areas of the Caribbean, the Pacific Islands, Central America, South America, Southeast Asia, the Middle East, and Africa. Limited autochthonous outbreaks have occurred in Europe. Local spread has occurred occasionally in the United States (in 2015-2016 in Hawaii; in 2022, 2 cases in Arizona; in 2023, at least 11 locally spread cases were reported in Florida and 1 case reported in Texas as of September 13, 2023; a case was also reported in California).

Worldwide, there are estimated to be 400 million dengue virus infections each year, with 100 million cases of illness and 40 000 deaths. Approximately 4 billion people live in areas with a risk of dengue. Brazil is experiencing a surge in cases of dengue fever in 2024, with dengue outbreaks declared in several states.

Travelers can present once home due to a 2- to 7-day incubation period. Clinical manifestations vary and include asymptomatic infection (75% of cases), mild dengue, classic dengue, and dengue hemorrhagic fever.

In classic dengue fever, there is a biphasic pattern to symptoms. During the first phase, there is an abrupt onset of fever for 2-5 days, malaise, chills, severe headache, myalgias, and retro-orbital and lumbosacral pain. The fever may climb as high as 41°C (105.8°F) but is not associated with an increased pulse. There can be a faint, transient diffuse morbilliform macular rash during the first few days.

During the next several days, there is defervescence despite the onset of nausea, vomiting, possible cough, rhinitis, and sore throat. Leukopenia, thrombocytopenia, and hemorrhagic manifestations are possible.

In young children with dengue fever, nonspecific symptoms such as refusing to accept oral fluids and foods, restlessness, abdominal pain, skin mottling, cold sweat, and low urine output may present early in the disease course.

Incidence is associated with increased urbanization in endemic areas. There is increased severity and 10%-30% mortality in children.

In October 2013, discovery of a new dengue virus serotype, dengue 5, was announced; it is thought to be phylogenetically distinct from the other 4 types.

Transmission of dengue virus via allogeneic blood cell transplantation has been documented, and patients with sickle cell disease or trait may be at increased risk of death from dengue.

The hemorrhagic form, dengue hemorrhagic fever (DHF), is believed to be more likely to occur during a second infection with the dengue virus, especially if the second infection involves a different serotype. DHF affects approximately 500 000 people annually and is most common in children younger than 15 years.

DHF typically begins with the abrupt onset of high fever (40°C-41°C [104°F-105.8°F]), facial flushing, circumoral cyanosis, and headache. Sore throat, anorexia, weakness, abdominal pain, nausea, and vomiting are common. This febrile phase lasts for 2-7 days and may be accompanied by a maculopapular rash, similar to dengue fever. DHF can be distinguished from dengue fever by accompanied petechiae and nonpalpable purpura present on the extremities, trunk, and face, as well as potential bleeding from the nose, gums, and gastrointestinal (GI) tract. Moderate cases will resolve after the fever subsides. However, after a few febrile days, the critical stage of plasma leakage may occur following a rapid drop in temperature. Circulatory failure accompanied by diaphoresis with cool extremities and shock may herald dengue shock syndrome (DSS). Death rates of up to 20% are reported and usually occur within 24 hours of DSS.

Codes

ICD10CM:
A90 – Dengue fever [classical dengue]

SNOMEDCT:
38362002 – Dengue

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:11/17/2021
Last Updated:02/19/2024
Copyright © 2024 VisualDx®. All rights reserved.
Patient Information for Dengue fever
Print E-Mail Images (21)
Contributors: Medical staff writer
Premium Feature
VisualDx Patient Handouts
Available in the Elite package
  • Improve treatment compliance
  • Reduce after-hours questions
  • Increase patient engagement and satisfaction
  • Written in clear, easy-to-understand language. No confusing jargon.
  • Available in English and Spanish
  • Print out or email directly to your patient
Copyright © 2024 VisualDx®. All rights reserved.
Dengue fever
A medical illustration showing key findings of Dengue fever (Classic Dengue Fever, Phase 1) : Fever, Facial flushing, Headache, Arthralgia, Myalgia, Retro-orbital pain, Mosquito bite
Clinical image of Dengue fever - imageId=423445. Click to open in gallery.  caption: 'A close-up of erythematous macules and papules.'
A close-up of erythematous macules and papules.
Copyright © 2024 VisualDx®. All rights reserved.